Stay updated on Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma
Sign up to get notified when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.

Latest updates to the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page
- Check4 days agoChange DetectedThe page updated to revision v3.0.2 (from v3.0.1), and the 'Back to Top' link was removed.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.2%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as various types of proteins and antibodies, while removing several disease-related terms and previous location details.SummaryDifference2%
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated to include new information about a clinical trial for recurrent glioblastoma, including details about the study's design, eligibility criteria, and treatment protocols. Additionally, it now features a disclaimer regarding the U.S. government's review of studies listed on the site.SummaryDifference100%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check48 days agoChange DetectedThe page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.9%
Stay in the know with updates to Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.